Filing Details
- Accession Number:
- 0001209191-14-068461
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-13 12:52:29
- Reporting Period:
- 2014-11-12
- Filing Date:
- 2014-11-13
- Accepted Time:
- 2014-11-13 12:52:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1444380 | Nevro Corp | NVRO | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1388325 | A/S Novo | Tuborg Havnevej 19 Hellerup G7 2900 | No | No | Yes | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-11-12 | 1,979,841 | $0.00 | 1,979,841 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2014-11-12 | 215,000 | $18.00 | 2,194,841 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series C Preferred Stock | Disposition | 2014-11-12 | 1,979,841 | $0.00 | 1,979,841 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct |
Footnotes
- The Series C Preferred Stock (the "Preferred Stock") had no expiration date and was convertible at any time at the holder's election. Upon the closing of the Issuer's initial public offering, the Preferred Stock automatically converted on a one-for-one basis for no additional consideration into the Issuer's common stock. The number of shares reported on this line item reflect the number of shares of the Issuer's common stock as adjusted for the 1-for-24 reverse split of common stock effected by the Issuer prior to the effectiveness of the registration statement.